Why WPP PLC, AstraZeneca plc and Meggitt plc Should Beat The FTSE 100 Today

WPP PLC (LON: WPP), AstraZeneca plc (LON: AZN) and Meggitt plc (LON: MGGT) bring us good news.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So for months, every time the prospect of US stimulus-reduction is even mentioned, investors run for the hills and the FTSE 100 (FTSEINDICES: ^FTSE) takes a tumble. Then when it actually happens — the Federal Reserve has decided to cut bond purchases by $10bn per month to $75bn — the FTSE rises! It’s up 64 points since the decision was known, to 6,556.

It might be the simultaneous commitment to maintaining low interest rates that has led to this reaction, but it shows that trying to second-guess the market’s short-term movements is a mug’s game.

Anyway, which individual FTSE 100 shares are rising today? Here are three:

WPP

WPP (LSE: WPP) shares gained 30p (2.3%) to 1,328p on the announcement of a new acquisition by the marketing giant.

One of WPP’s subsidiaries, GroupM, is to buy up a majority stake in ClickMedia which operates in Vietnam. Described as “a full service social media marketing firm“, ClickMedia counts Unilever and Estee Lauder amongst its customers, and had revenues of 23.7 billion dong (£687,300) for the year to December 2012. 

WPP shares are now up 50% over the past 12 months.

AstraZeneca

The day got off to a good start for AstraZeneca (LSE: AZN) (NYSE: AZN.US), with a 59p (1.7%) boost to 3,596p, taking the price up more than 20% since this time last year.

Again there was an acquisition behind it, with the drugs giant telling us it “will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance“. AstraZeneca will pay $2.7bn up front followed by up to $1.4bn depending on agreed performance targets, and there will be various other smaller sums applicable for royalties and some assets.

Since his arrival, chief executive Pascal Soriot has been focusing on the company’s core assets and strengths, and this is clearly a positive move in that direction.

Meggitt

Aerospace and defence engineer Meggitt (LSE: MGGT) has been awarded a contract worth US$18m by the Australian Defence Force, for providing hardware and software upgrades to a number of existing projects.

The deal comes on the heels of a number of big international contracts totalling $40m, from Italy, Kuwait, Singapore and the US.

Meggitt shares picked up 7.5p (1.5%) to 511p in response to the news. 

Alan does not own any shares mentioned in this article. 

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

How much do you need in an ISA to target £8,333 a month of passive income?

Our writer explores a potential route to earning double what is today considered a comfortable retirement and all tax-free inside…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Could these 3 FTSE 100 shares soar in 2026?

Our writer identifies a trio of FTSE 100 shares he thinks might potentially have more petrol in the tank as…

Read more »

Pakistani multi generation family sitting around a table in a garden in Middlesbourgh, North East of England.
Dividend Shares

How much do you need in a FTSE 250 dividend portfolio to make £14.2k of annual income?

Jon Smith explains three main factors that go into building a strong FTSE 250 dividend portfolio to help income investors…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

275 times earnings! Am I the only person who thinks Tesla’s stock price is over-inflated?

Using conventional measures, James Beard reckons the Tesla stock price is expensive. Here, he considers why so many people appear…

Read more »

Investing Articles

Here’s what I think investors in Nvidia stock can look forward to in 2026

Nvidia stock has delivered solid returns for investors in 2025. But it could head even higher in 2026, driven by…

Read more »

Investing Articles

Here are my top US stocks to consider buying in 2026

The US remains the most popular market for investors looking for stocks to buy. In a crowded market, where does…

Read more »

Investing Articles

£20,000 in excess savings? Here’s how to try and turn that into a second income in 2026

Stephen Wright outlines an opportunity for investors with £20,000 in excess cash to target a £1,450 a year second income…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is a 9% yield from one of the UK’s most reliable dividend shares too good to be true?

Taylor Wimpey’s recent dividend record has been outstanding, but investors thinking of buying shares need to take a careful look…

Read more »